Uveitis Completed Phase 2 Trials for Everolimus (DB01590)

Also known as: Unspecified iridocyclitis / Uveitis NOS / Uveitis (disorder)

IndicationStatusPhase
DBCOND0009937 (Uveitis)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00803816Everolimus for the Treatment of Uveitis Unresponsive to Cyclosporine ATreatment